Finish Line has played the â??material adverse effectâ?? card in its battle to break off its acquisition of Genesco.
The Indianapolis company didnâ??t elaborate in yesterdayâ??s SEC filing, but Finish Line has repeatedly made clear that encountering
problems with long-term implications would mean the deal is off.
Should a downturn in Genescoâ??s financial performance count as a material change? Read the story.